- Scrip Originals
- Featured Topics
Wuhan Rhecogen Biotechnology Co., Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Wuhan Rhecogen Biotechnology Co., Ltd.
The leader in China's homegrown mRNA COVID-19 vaccine effort expects a delay to key Phase III results, with analysts now expecting to see figures from the international portion of the study in early 2022.
- Antisense, Oligonucleotides